Blood test detects early stages of Alzheimer’s disease
European Pharmaceutical Review | February 05, 2018
Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. Scientists have teamed up to develop and validate a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. The blood test measures a specific peptide in the blood to inform scientists, with 90 percent accuracy, if a patient has the very earliest stages of Alzheimer’s disease.